Relationship between overall survival and time to progression after transarterial chemoembolization therapy in patients with hepatocellular carcinoma

Tadaaki Arizumi; Kazuomi Ueshima; Masatoshi Kudo

doi:10.1016/s0168-8278(17)31683-5

Related publications

Article2017

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

Tadaaki Arizumi, Kazuomi Ueshima, Mina Iwanishi, Tomohiro Minami, Hirokazu Chishina, Masashi Kono, Masahiro Takita, Norihisa Yada, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Yoriaki Komeda, Mamoru Takenaka, Toshiharu Sakurai, Tomohiro Watanabe, Naoshi Nishida, Masatoshi Kudo

Article2017

Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases

Hirofumi Izumoto, Atsushi Hiraoka, Yoshihiro Ishimaru, Tadashi Murakami, Shogo Kitahata, Hidetaro Ueki, Toshihiko Aibiki, Tomonari Okudaira, Yuji Miyamoto, Hiroka Yamago, Ryuichiro Iwasaki, Hideomi Tomida, Kenichiro Mori, Masato Kishida, Eiji Tsubouchi, Hideki Miyata, Tomoyuki Ninomiya, Hideki Kawasaki, Masashi Hirooka, Bunzo Matsuura, Masanori Abe, Yoichi Hiasa, Kojiro Michitaka,

Article2019

Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization

Masatoshi Kudo

Article2017

Weak correlation of overall survival and time to progression in advanced hepatocellular carcinoma.

Liping Huang, Yoriko De Sanctis, Minghua Shan, Jordi Bruix, Josep M. Llovet, Ann‐Lii Cheng, Gerold Meinhardt, Keiko Nakajima

Journal of Clinical Oncology

Article2014

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Masatoshi Kudo, Guohong Han, Richard S. Finn, Ronnie T.P. Poon, Jean–Frédéric Blanc, Lünan Yan, Jijin Yang, Ligong Lu, Won Young Tak, Xiaoping Yu, Joon-Hyeok Lee, Shi‐Ming Lin, Changping Wu, Tawesak Tanwandee, Guoliang Shao, Ian Walters, Christine Dela Cruz, Valerie Poulart, Jianhua Wang

Relationship between overall survival and time to progression after transarterial chemoembolization therapy in patients with hepatocellular carcinoma

Discussion(0)

Related publications

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases

Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization

Weak correlation of overall survival and time to progression in advanced hepatocellular carcinoma.

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial